SCHEMBL659968

SCHEMBL659968

O=C(NCCO)C1=CN(CC(=O)c2ccc(Br)cc2)C=CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.37
ALDH1A1 P00352 2/20 0.36
GSK3B P49841 2/20 0.35
MAPT P10636 3/20 0.35
RAB9A P51151 2/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 1/20 0.35
HAO1 Q9UJM8 1/20 0.35
MGAM O43451 1/20 0.34
AMY1A P0DUB6 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
POLB P06746 2/20 0.34
HPGD P15428 1/20 0.34
CA12 O43570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL658639 0.79 ALDH1A1 (0.39) ALDH1A1GSK3BMAPTRAB9AHTT
SCHEMBL661019 0.77 NPSR1 (0.43) TSHRALDH1A1GSK3BRAB9AHTT
SCHEMBL658611 0.77 CA12 (0.32) ALDH1A1MAPTCA12CA1CA2
SCHEMBL298474 0.74 SMN1; SMN2 (0.40) TSHRALDH1A1GSK3BMAPTRAB9A
SCHEMBL27854975 0.73 ALDH1A1 (0.37) ALDH1A1GSK3BMAPTRAB9AHTT
SCHEMBL660154 0.73 SMN1; SMN2 (0.39) TSHRALDH1A1GSK3BMAPTRAB9A
SCHEMBL1665183 0.70 OGG1 (0.59) TSHRALDH1A1RAB9AHTTSMN1; SMN2
SCHEMBL14067679 0.70 LMNA (0.38) TSHRALDH1A1MAPTHTTCYP2C19
SCHEMBL7805087 0.70 HDAC1 (0.40) ALDH1A1MAPTRAB9ASMN1; SMN2CYP3A4
SCHEMBL27854995 0.69 ALDH1A1 (0.41) TSHRALDH1A1GSK3BMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US claimed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT TSHR 4816/4885ALDH1A1 676/4885GSK3B 1822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.